Abstract:Postzygotic single-nucleotide mosaicisms (pSNMs) have been extensively studied in tumors and are known to play critical roles in tumorigenesis. However, the patterns and origin of pSNMs in normal organs of healthy humans remain largely unknown. Using whole-genome sequencing and ultra-deep amplicon re-sequencing, we identified and validated 164 pSNMs from 27 postmortem organ samples obtained from five healthy donors. The mutant allele fractions ranged from 1.0% to 29.7%. Inter- and intra-organ comparison revealed two distinctive types of pSNMs, with about half originating during early embryogenesis (embryonic pSNMs) and the remaining more likely to result from clonal expansion events that had occurred more recently (clonal expansion pSNMs). Compared to clonal expansion pSNMs, embryonic pSNMs had higher proportion of C>T mutations with elevated mutation rate at CpG sites. We observed differences in replication timing between these two types of pSNMs, with embryonic and clonal expansion pSNMs enriched in early- and late-replicating regions, respectively. An increased number of embryonic pSNMs were located in open chromatin states and topologically associating domains that transcribed embryonically. Our findings provide new insights into the origin and spatial distribution of postzygotic mosaicism during normal human development. Author Summary Genomic mosaicism led by postzygotic mutation is the major cause of cancers and many non-cancer developmental disorders. Theoretically, postzygotic mutations should be accumulated during the developmental process of healthy individuals, but the genome-wide characterization of postzygotic mosaicisms across many organ types of the same individual remained limited. In this study, we identified and validated two types of postzygotic mosaicism from the whole-genomes of 27 organs obtained from five healthy donors. We further found that the postzygotic mosaicisms arising during early embryogenesis and later clonal expansion events show distinct genomic patterns in mutation spectrum, replication timing, and chromatin status.

Mosaicism in health and disease — clones picking up speed

Human embryonic genetic mosaicism and its effects on development and disease

Mosaicism in Human Health and Disease.

Illegitimate and Repeated Genomic Integration of Cell-Free Chromatin in the Aetiology of Somatic Mosaicism, Ageing, Chronic Diseases and Cancer

Genomic Mosaicism Formed by Somatic Variation in the Aging and Diseased Brain

Dynamic nature of somatic chromosomal mosaicism, genetic-environmental interactions and therapeutic opportunities in disease and aging

Distinctive types of postzygotic single-nucleotide mosaicisms in healthy individuals revealed by genome-wide profiling of multiple organs

Body-wide chimerism and mosaicism are predominant causes of naturally occurring ABO discrepancies

Somatic mosaicism detected by genome-wide sequencing in 500 parent-child trios with suspected genetic disease: clinical and genetic counseling implications

De novo mutations, genetic mosaicism and human disease

Genotype-to-phenotype mapping of somatic clonal mosaicism via single-cell co-capture of DNA mutations and mRNA transcripts

Recent advances in the study of somatic mosaicism and diseases other than cancer

Chimerism and mosaicism shape our physical constitution and impact medical conditions

Cell-type-resolved mosaicism reveals clonal dynamics of the human forebrain

Somatic mosaicism in the diseased brain

The Clinical Spectrum of Mosaic Genetic Disease

Ontogenetic and Pathogenetic Views on Somatic Chromosomal Mosaicism

Large, three-generation human families reveal post-zygotic mosaicism and variability in germline mutation accumulation

Single-cell analysis of human embryos reveals diverse patterns of aneuploidy and mosaicism

Four-dimensional, Dynamic Mosaicism is a Hallmark of Normal Human Skin That Permits Mapping of the Organization and Patterning of Human Epidermis During Terminal Differentiation.

Extensive phylogenies of human development inferred from somatic mutations